The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 , ., Its not a steroid, its a peptide , ., Potential benefits aid soft tissue repair, bone density and reduce inflammation , ., The catch , classified as unlicensed medicine so Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review BPC Original Infiniwell